Acasti Pharma reported $55.48M in Operating Expenses for its fiscal quarter ending in September of 2026.





Operating Expenses Change Date
Acasti Pharma USD 55.48M 7.27M Sep/2026
Addus HomeCare USD 347.92M 9.44M Sep/2026
Amarin USD 51.48M 113K Dec/2025
Cassava Sciences USD 9.39M 1.78M Jun/2026
Knight Therapeutics CAD 126.9M 8.29M Dec/2025
Option Care Health USD 1.4B 47.05M Sep/2026
Organigram Holdings CAD 100.45M 30.86M Jun/2026
Tilray USD 237.52M 17.34M Sep/2025